ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company's lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as well as antifungal, cosmetics, and pain management products. In addition, company develops anti-aging skin care, pain management, hair-loss, and toenail fungus products. It also provides licenses for its technology for pharmaceutical industry in various therapeutic areas. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Las Vegas, Nevada.
Frequently asked questions
What sector does Viaderma Inc (VDRM) operate in?
Viaderma Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Viaderma Inc (VDRM) current stock price?
As of the latest data, Viaderma Inc stock price is $0.00, with a previous close of $0.00.
What is Viaderma Inc (VDRM) current market capitalization?
Viaderma Inc market cap is approximately 123.37 thousand.
Does Viaderma Inc (VDRM) pay dividends?
No. Viaderma Inc does not pay a dividend.
What is Viaderma Inc (VDRM) beta (volatility) score?
Viaderma Inc has a beta of 0.152, indicating lower volatility than the overall market.